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In vitro responsiveness to serum growth factors is inversely related to
in vivo malignancy in human thyroid epithelial cells
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Summary We have examined the proliferative response (DNA synthesis) of primary thyroid epithelial
cultures to serum and a defined serum-substitute. These cultures were derived from normal human thyroid and
from thyroid adenomas and carcinomas. All normal cultures showed a dose-dependent response, with a
maximum 3H-thymidine labelling index of around 50%. Three out of the four adenomas demonstrated a much
reduced or delayed response under the same conditions. In two carcinomas, labelling was never more than 5%
and in one case was undetectable. This inverse relationship between the degree of in vivo malignancy and
proliferative response in vitro has important implications for the interpretation of tissue culture models of
epithelial neoplasia and also offers the potential for isolating novel growth factors specific for thyroid cancer
cells.
The thyroid provides a convenient experimental model for
studying the molecular basis of human epithelial malignancy.
Like colon, it provides a well-defined spectrum of benign and
malignant tumours, but offers the important advantage of a
much simpler tissue organisation. Indeed, if the tiny comple-
ment of C cells is ignored, the normal thyroid effectively
contains a homogeneous population of epithelial cells in a
single differentiation and cell kinetic state (Wynford-Thomas
& Williams, 1989). In addition, the structural organisation
into follicles (which is fortunately preserved in many differ-
entiated tumours) greatly facilitates preparation of pure
primary cultures of these epithelial cells free of stromal
contamination (Williams et al., 1987; Williams & Wynford-
Thomas, 1990) from both normal and neoplastic tissue.
Clearly a major application of this experimental system is
the direct comparison of proliferative and biochemical re-
sponses to growth factors of normal, benign and malignant
thyroid epithelium. We have already successfully employed
this approach to demonstrate an important difference in the
requirement for insulin-like growth factor 1 (IGF-1) between
normal and benign thyroid tumour cells (Williams et al.,
1988) and obtained evidence pointing to autocrine produc-
tion in the latter (Williams et al., 1989).
In attempting to extend this work to malignant epithelia
we were surprised to find that although viable monolayers
were readily obtainable from thyroid cancers, they showed a
striking lack of proliferative activity (DNA synthesis) com-
pared to both normal and adenoma-derived cultures. We
have therefore carried out a systematic comparison of the
responsiveness of normal, benign and malignant thyroid
epithelia to serum growth factors.
Materials and methods
Tissue
Tumour tissue was obtained fresh from surgical thyroid-
ectomies performed for removal of a 'solitary thyroid
nodule', samples (adenoma or carcinoma) being dissected out
from the centre of the nodule. Normal tissue, in three cases,
was taken from the periphery of the lobectomy specimen,
distant from the tumour, in a macroscopically normal region.
In addition fresh normal tissue was also obtained from a 30
year old transplant donor patient with no thyroid disease and
normal histology (graph c, Figure 1; case III, Figure 2).
Histological confirmation of the normal or neoplastic
status of each sample was carried out retrospectively.
Four adenomas were studied (Table I). All were solitary,
encapsulated tumours and were classified as macro- or micro-
follicular on the basis of follicle size relative to normal, as in
previous studies (Lemoine et al., 1989). None showed evi-
dence of capsular or vascular invasion on examination of
multiple tissue blocks.
Three carcinomas were studied (Table I). Two were
minimally invasive follicular carcinomas of good-to-moderate
differentiation with the histological appearance of an
adenoma except for the presence of definite capsular or
angio-invasion, this being the essential diagnostic criterion of
malignancy. The third was a moderately-differentiated wide-
ly-invasive follicular carcinoma.
Primary culture
Both normal and tumour derived cultures were prepared by
collagenase/dispase digestion together with mechanical dis-
aggregation as described previously (Williams et al., 1988;
Williams & Wynford-Thomas, 1990). The resulting >95%
pure epithelial cultures were aliquotted in a mix of 10%
DMSO/45% New-born calf serum/45% RPMI 1640, frozen
slowly and stored in liquid nitrogen until required.
Proliferation assay
Monolayers were seeded at approximately 2 x 105 cells per
35 mm dish (Falcon) in RPMI 1640 medium (Flow) supple-
mented with 10% foetal calf serum (FCS, Imperial Labora-
tories) and allowed to attach for 18-24 h. Cultures were then
washed three times with serum-free medium and maintained
serum-starved for 3 days to reach a basal state. This treat-
ment showed no adverse affect on viability. Proliferation
assays were started by replacing the serum free medium with
fresh RPMI containing appropriate concentrations of FCS or
Ultraser-G to replicate dishes. (Ultraser-G is a defined serum
substitute suitable for epithelial cell culture consisting of a
mixture of growth factors, trace elements and attachment
factors manufactured by IBF Biotechnics and distributed by
Gibco-BRL; the exact composition is undisclosed.) All FCS
for these experiments was derived from the same batch to
exclude the possibility of inter-batch variability though other
batches tested in pilot studies gave essentially the same
results. Response was assessed in terms of entry into S phase
(DNA synthesis) by autoradiographic determination of the
proportion of nuclei labelled after incubation in 2 iCi ml-'
3H-thymidine (3H-TdR) (41 Ci mmol '; Amersham). Succes-
sive 48 h labelling periods were used as in previous studies
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Figure 2 Dose-response relationships for FCS (a-c) and Ultra-
ser-G (d-f). For each FCS and US concentration, the highest
48 h LI observed during the first three labelling periods is shown.
Normals (a, d): (-) case I; (A) case II; (0) case III; (+) case
IV. Adenomas (b, e): (U) case SR; (A) case JB; (0) case SA;
(+) case ER. Carcinomas (c, f) (+) case AH; (A) case MW; (0)
case WH.
(Williams et al., 1988), sets of replicate dishes being labelled
0-2, 2-4, 4-6 or 6-8 days after addition of serum/growth
factors. After labelling, dishes were fixed in methanol:acetic
acid (3:1), coated with Ilford K2 emulsion, autoradiographed
for 4 days and counterstained with Giemsa. For each data
point, the labelling index (LI) was determined from a random
count of 1000 nuclei in three dishes. Results are expressed as
means ± standard error (s.e.).
Figure 1 Proliferative responses to foetal calf serum of human
follicular cells in primary culture derived from normal thyroid
(a-d) and from thyroid adenomas (e-h; e - case SR; f- case JB;
g - case SA; b - case ER). Each point gives the mean percentage
of nuclei labelled after a 48 h labelling period in 3H-TdR from
0-2, 2-4, 4-6 and 6-8 days after addition of the following
concentrations of FCS to serum-starved cultures: (0) 0% FCS;
(A) 1% FCS; (U) 5% FCS; (+) 10% FCS. Error bars are not
shown where they lie within the symbol marking the data point.
Table I Thyroid tumour cases studied
Case Age Sex Pathologicalfeatures
Adenomas
SR 40 F Macrofollicular
JB 54 F Macrofollicular
SA 32 M Microfollicular
ER 49 F Macrofollicular
Carcinomas
AH 42 F Minimally-invasive
MW 13 M Minimally-invasive
WH 70 M Widely-invasive
Results
Follicular cells derived from normal thyroid tissue and from
benign and malignant tumours attached and spread to form
epithelial islands within 24 h of plating in 10% FCS. All
monolayers were able to remain viable for over 10 days of
serum starvation.
Response to FCS
Normal epithelium All four cultures of normal follicular
cells (taken from four separate thyroids) showed a similar
pattern of proliferative response to serum. Addition of 10%
FCS to quiescent, serum starved, cells stimulated entry into
DNA synthesis as shown by a rise in the 48 h 3H-TdR
labelling index from less than 1% in the absence of serum to
between 15 and 25% in the first 2 days after serum addition,
reaching a maximum of 45% to 55%, in most cases at days
4-6 (Figures la-d). Lower concentrations of serum induced
in most cases a similar time course (Figures la-d) but in all
cases a lower magnitude response (Figure 2a).
Adenoma epithelium Adenoma cultures also showed a very
low basal proliferation in the absence of serum (LI <1%).
Addition of FCS, even at 10%, induced a lower magnitude
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response in adenoma cultures (three out of four) than that
seen in the normal cells (Figure 2b). The maximum 48 h LI
was only 5.5 ± 0.7% (mean ± s.e.) in one case (SR, Figure
le) and 11.6 ± 2.9% in a second (JB, Figure If). A third case
(SA) eventually reached a higher figure of 34%, but with a
much slower time course than seen in the normal, the day
2-4 LI being only 2.8% (Figure Ig). Only one adenoma out
of the four (case ER) gave a magnitude and time course
similar to normal (Figure lh). In the case of SR (Figure le),
the reduction in response was even more evident at lower
serum concentrations; no labelled nuclei were detectable in
1% or 5% FCS.
Carcinoma epithelium Due to the rarity of these cases and
the restricted supply of cells, a more limited analysis was
performed. In the one case (AH) in which a full time course
(of three 48 h labelling periods) was carried out, the 48 h LI
remained well below 1% in all labelling periods and at all
FCS concentrations (0%, 1%, 5% and 10%; Figure 2c). In
the other minimally invasive case (MW) two labelling periods
were studied, days 2-4 and 4-6. LI values of 3.7% ± 0.7%
and 4.6% ± 0.4% respectively were observed in 10% FCS. In
the widely-invasive case (WH) a single labelling period, day
2-4, showed an LI of 2.9% ± 0.3% in 10% FCS.
Response to Ultraser-G
We considered the possibility that the lack of responsiveness
particularly in carcinoma cells may have resulted from an
inhibitory activity present in our batch of FCS, or indeed in
FCS in general. To address this, and to facilitate subsequent
reproducibility of these findings, we therefore re-analysed a
sub-set of our cases using a commercial serum-substitute,
Ultraser-G (Gibco).
Ultraser-G (US) induced a closely similar temporal pattern
of response in both normal and adenomas to that seen with
FCS. The highest concentration used, 2%, was that reported
in other cell types to be equivalent to 10% FCS. In our cells
however the maximum response to 2% US in all normals
and adenomas was lower, being similar to that induced by 1
to 5% FCS (Figure 2d,e). The relative reduction in reson-
siveness to FCS of adenomas compared to normals was also
observed for US in all three cases tested (SR, JB and SA,
Figure 2e). Furthermore, no response to US was detectable
in the one carcinoma tested (AH, Figure 2f).
Discussion
We have shown here that the proliferative response of
thyroid follicular cells to serum growth factors (as indicated
by DNA synthesis) is inversely proportional to the degree of
in vivo malignancy. Three out of four adenomas showed a
markedly reduced response compared to normal thyroid epi-
thelium, and all three carcinomas demonstrated an even
lower response than the adenomas, with no significant stimu-
lation even by 10% FCS. The apparently normal response of
the fourth adenoma could not be explained on the basis of
any obvious clinical or pathological variable. However, it is
entirely possible that the molecular pathology responsible for
tumour formation in this case may be different despite the
similarity in the histological appearance. For example, we
have previously shown that an activated ras oncogene is
present in 30% of thyroid adenomas (Lemoine et al., 1989).
This suggests a different molecular pathology exists in the
remaining 70% of adenomas.
The chief question arising from these observations is why malignant thyroid follicular cells, which show an enhanced
proliferative capacity relative to the normal in vivo, should
show such a paradoxical reduction in growth response in
vitro?
There is of course a precedent for this in other epithelial tissues. It has been known for many years that breast carcin-
oma cells are more difficult to culture than the corresponding normal. Quantitative comparisons have confirmed this lower
response to serum and/or purified growth factors (Kirkland
et al., 1979) and indicate, as in thyroid, an inverse correlation
between in vivo malignancy and in vitro growth (Buehring &
Williams, 1976). The prostate demonstrates a broadly similar
picture, carcinomas showing little growth in vitro compared
with normal epithelium (Smith & Dollbaum, 1981).
This is not always the case however, since in tumours of
the colon (Pareskeva et al., 1984) and pancreas (N.R.
Lemoine - personal communication) the opposite holds true,
with carcinoma growing better than adenoma, which in turn
grows better than normal tissue.
One simple explanation for an apparent loss of response in
cancer cells which, as far as we are aware has not been
excluded in the past, is the possibility that the tumour cells
have a 'bell-shaped' dose-response curve to serum and that a
potential peak has been missed by failing to examine low
enough serum concentrations. We addressed this by carrying
out a full dose-response study from 1% to 10% FCS (and in
a sub-set of cases continuing down to 0.5% and 0.2% FCS -
data not shown). No evidence for any lower concentration
peak could be found in thyroid tumour cells.
A second possible cause for reduced response could be the
presence of inhibitory factors in the foetal calf serum to
which neoplastic and in particular malignant cells are more
sensitive. The fact that the same overall pattern of response
was seen using a commercial serum substitute, suitable for
epithelial cells (Ultraser-G), makes this less likely. Although
the exact composition is undisclosed, it is reasonable to
assume that growth factors known to be inhibitory to epithe-
lial cells in culture (e.g. TGF-P [Roberts et al., 1988]) are
unlikely to be included in its composition.
We believe therefore, that the lack of proliferation is due
to a deficiency in one or more positive signals on which the
follicular cell becomes increasingly dependent as it acquires
greater malignant potential (although one cannot entirely
exclude 'intracellular' events such as loss of growth factor
pathways which are irrelevant/inhibitory in vivo, but essential
in vitro, or conversely activation of pathways stimulatory in
vivo, but inhibitory in vitro). Clearly such permissive factors
may be either diffusible extracellular growth factors and/or
immobilised 'solid-phase' signals such as matrix attachment
factors, provided in vivo by stromal cells but absent in our
cultures. The normal cell is presumably less dependent either
because it produces its own factor(s) or because these signals
are not required. Thomas-Morvan et al. (1983) reported
growth of normal, adenoma and carcinoma cells from
thyroid on a collagen matrix. In our hands however, use of
Transwell (porous collagen support) dishes (Costar) or the
more complex artificial basement membrane, Matrigel (Col-
laborative Research Inc) failed to permit any observable
growth. Co-culturing with mitomycin-C-treated Swiss 3T3
fibroblasts or normal human thyroid fibroblasts as feeder
cells has also proved unsuccessful.
The paradoxical refractory nature of cancer cells is both a
hindrance and a potential asset. Clearly it limits at present
the availability of mass cultures for biochemical or molecular
analysis. However, this lack of proliferation can also be
turned to advantage. It offers the possibility ofusing primary
thyroid cancer cells as an assay for isolating novel permissive
growth factors or matrix components required specifically for
cancer growth.
A major advance towards this goal would be the ability to
reversibly switch on cancer cell growth in vitro. Recent
studies of the tumour suppressor gene p53 (Bartek et al., 1990) demonstrate that in that minority of cases where lines
have been obtained from breast cancers, they have a muta-
tion of this gene which appears to abolish its tumour
suppressor activity and additionally inhibits the action of
normal p53. Furthermore, in the one known case of differen-
tiated thyroid cancer in which a line was obtained (from
more than 100 cases; Goretzki et al., 1989) - FTC 133 - we
have recently shown that this too, has a p53 mutation (Wyl-
lie et al. - in publication; Wright et al. - submitted). This
therefore strongly suggests that whatever the basis for the
lack of growth response in cancer cells, it may be directly900 T.P. DAWSON et al.
overcome by the expression of a mutant p53. The recent
availability ofa temperature-sensitive mutant ofp53 (Michal-
ovitz et al., 1990) now raises the exciting possibility that
introduction of this gene into primary thyroid carcinoma
cells would generate lines with inducible growth which would
be the ideal substrate for isolating the missing stimuli for in
vitro cancer growth.
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